Dec. 9 at 9:54 PM
$SANA there isn't any news to warrant the drop the past 2 days. Stock is still undervalued (this is solidly a
$12 stock minimum, Vertex paid >
$2B for their program w/ no anti-rejection tech,
$SANA is worth >
$3B, period). Nobody else in the world has been able to get non-self cells to survive without immunosuppression in a human for as long as Sana has, not even close. Without immunosuppression, the cells would have been rejected within 1-2 weeks. Having them last 6 months, as Sana has reported in the world's best medical journal, is just absolutely nuts. If they survived 6 months, they WILL survive 1 year. The data showing
$SANA's immune evasion tech worked was the 6 month data. If you want to hold out buying until 1 year data comes out, fine, but the data already tells us that the tech works.
My best guess at explaining price action past 2 days is shenanigans by big money to get cheaper shares before rate cut decision tomorrow and/or impending 1 year data. This is a buying opportunity.
